Agios Pharmaceuticals, Inc. Common Stock (NASDAQ: AGIO) last traded at $33.09, down 1.61% on the session. The quote above updates while this page is open; the figures below are drawn from Agios Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Agios Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker AGIO. Its market capitalisation is $1.98 billion.
Valuation measures for Agios Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.98B |
|---|---|
| Enterprise value | $1.96B |
| Price / sales | 20.09 |
| Price / book | 1.93 |
| Beta | 0.53 |
Trailing-twelve-month figures tagged in Agios Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $98.34M |
|---|---|
| Net income (TTM) | -$411.29M |
| EPS (TTM) | -$7.02 |
| Operating margin | -466.78% |
| Return on equity | -40.09% |
| Cash | $99.65M |
Range and volume for AGIO over the past 52 weeks.
| 52-week high | $46.00 |
|---|---|
| 52-week low | $22.24 |
| Volume | 559.0K |
| Average volume | 1.16M |
| Previous close | $33.63 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.